ZAP-70 EXPRESSION IS ASSOCIATED WITH INCREASED RISK OF AUTOIMMUNE CYTOPENIAS IN CLL PATIENTS
Résumé
Autoimmune cytopenias (AIC) are frequent in CLL patients, but risk factors and prognostic relevance of these events are controversial. Data about the influence on AIC of biological prognostic markers, as ZAP-70, are scanty. We retrospectively evaluated AIC in 290 CLL patients tested for ZAP-70 expression by immunohistochemistry on bone marrow biopsy at presentation. They were 185 males, median age 63 years, 77.9% Binet stage A, 17.6% B and 4.5% C. AIC occurred in 46 patients (16%): 31 autoimmune haemolytic anaemias, 10 autoimmune thrombocytopenias, 4 Evans syndromes and 1 pure red cell aplasia. Of the 46 cases of AIC, 37 (80%) occurred in ZAP-70positive patients and 9 (20%) in ZAP-70negatives. ZAP-70 expression (HR=7.42; 95%CI:2.49-22.05) and age >65 years (HR=5.41; 95%CI:1.67-17.49) resulted independent risk factors for AIC. Among the 136 patients evaluated for ZAP-70 expression and IGHV status the occurrence of AIC was higher in ZAP-70positive/IGHVunmutated cases (35%) than in patients ZAP-70negative/IGHVmutated (6%) or discordant for the two parameters (4%) (P<0.0001). In ZAP-70 positive patients occurrence of AIC negatively influenced survival (HR=1.75; 95% CI: 1.06-2.86). The high risk of developing AIC in ZAP-70positive CLL, particularly when IGHVunmutated, should be considered in the clinical management.
Origine : Fichiers produits par l'(les) auteur(s)
Loading...